Evidence map›Paper›PMID 33036021›Full record

ArticlePloS one2020

Mild-moderate CKD is not associated with cognitive impairment in older adults in the Alzheimer's Disease Neuroimaging Initiative cohort.

Aditi Gupta, Kevin Kennedy, Jaime Perales-Puchalt, David Drew, Srinivasan Beddhu, Mark Sarnak, Jeffrey Burns, Alzheimer’s Disease Neuroimaging Initiative

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.1field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Association of impaired kidney function with dementia and brain pathologies: A community-based cohort study.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2023
    Article
  3. Article
  4. Article
  5. Mild to moderate decrease in eGFR and cognitive decline in older adults.Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association · 2022
    Article
  6. Article
  7. Insights into Cognitive Brain Health in Chronic Kidney Disease.Gerontology & geriatrics : research · 2022
    Article
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Aditi GuptaThe Kidney Institute, University of Kansas Medical Center, Kansas City, KS, United States of America.ORCID 0000-0002-6286-802X
Kevin KennedyKansas City Veterans Affairs, University of Kansas Medical Center, Kansas City, KS, United States of America.
Jaime Perales-PuchaltAlzheimer's Disease Center, University of Kansas Medical Center, Kansas City, KS, United States of America.
David DrewDivision of Nephrology and Hypertension, Tufts Medical Center, Boston MA, United States of America.
Srinivasan BeddhuUniversity of Utah, Salt Lake City, UT, United States of America.
Mark SarnakDivision of Nephrology and Hypertension, Tufts Medical Center, Boston MA, United States of America.
Jeffrey BurnsAlzheimer's Disease Center, University of Kansas Medical Center, Kansas City, KS, United States of America.
Alzheimer’s Disease Neuroimaging Initiative
University of Kansas Medical Center · USTufts Medical Center · USUniversity of Utah · US

Funding

Alzheimer's Disease Neuroimaging Initiative - SupplementU01AG024904 · NIA · NORTHERN CALIFORNIA INSTITUTE RES &EDUC · PI WEINER, MICHAEL W · 2004 to 2015
$121.0M
University of Kansas Alzheimer's Disease Core CentersP30AG035982 · NIA · UNIVERSITY OF KANSAS MEDICAL CENTER · PI SWERDLOW, RUSSELL H. · 2011 to 2020
$16.6M
Heartland Institute for Clinical and Translational ResearchUL1TR000001 · NCATS · UNIVERSITY OF KANSAS MEDICAL CENTER · PI BAROHN, RICHARD J. · 2012 to 2015
$13.0M
Cognitive Impairment in End Stage Renal DiseaseK23AG055666 · NIA · UNIVERSITY OF KANSAS MEDICAL CENTER · PI GUPTA, ADITI · 2017 to 2022
$1.2M
The association of FGF-23 and Klotho with cognitive impairment and cerebrovascular disease in chronic kidney diseaseK23DK105327 · NIDDK · TUFTS MEDICAL CENTER · PI DREW, DAVID ALAN · 2016 to 2020
$958k
CIHRNCATS NIH HHS UL1 TR000001NIA NIH HHS K23 AG055666NIA NIH HHS P30 AG035982NIA NIH HHS U01 AG024904NIDDK NIH HHS K23 DK105327
6 · The paper itself

Abstract

backgroundChronic kidney disease (CKD) is associated with cognitive impairment and dementia. We examined whether this relationship hold true in older adults, who have a higher prevalence of both CKD and dementia. DESIGN, SETTING, PARTICIPANTS, AND MEASUREMENTS: We conducted a cross-sectional secondary analysis of an established observational cohort. We analyzed data from the Alzheimer's Disease Neuroimaging Initiative (ADNI), an NIH funded, multicenter longitudinal observational study, which includes participants with normal and impaired cognition and assesses cognition with a comprehensive battery of neuropsychological tests. We included a non-probability sample of all ADNI participants with serum creatinine measurements at baseline (N = 1181). Using multivariable linear regression analysis, we related the CKD Epidemiology Collaboration equation eGFR with validated composite scores for memory (ADNI-mem) and executive function (ADNI-EF).

resultsFor the 1181 ADNI participants, the mean age was 73.7 ± 7.1 years. Mean estimated glomerular filtration rate (eGFR) was 76.4 ± 19.7; 6% had eGFR<45, 22% had eGFR of 45 to <60, 51% had eGFR of 60-90 and 21% had eGFR>90 ml/min/1.73 m2. The mean ADNI-Mem score was 0.241 ± 0.874 and mean ADNI-EF score was 0.160 ± 1.026. In separate multivariable linear regression models, adjusted for age, sex, race education and BMI, there was no association between each 10 ml/ min/1.73 m2 higher eGFR and ADNI-Mem (β -0.02, 95% CI -0.04, 0.02, p = 0.56) or ADNI-EF (β 0.01, 95% CI -0.03, 0.05, p = 0.69) scores.

conclusionWe did not observe an association between eGFR and cognition in the older ADNI participants.

Indexed as

AgedAged, 80 and overAlzheimer DiseaseCognitionCognitive DysfunctionCohort StudiesFemaleGlomerular Filtration RateHumansMaleRenal Insufficiency, Chronic

Identifiers

PMID33036021
PMCPMC7546911
OpenAlexW3092292025

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.